Seeking Alpha

MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Galena Biopharma, Inc. (GALE) Partners With Dr. Reddy's Laboratories Ltd. (RDY) To Broaden Geographic Reach And Addressable Patient Population Of NeuVax 0 comments
    Jan 14, 2014 2:48 PM | about stocks: GALE

    Today before the opening bell, it was announced that Galena Biopharma and Dr. Reddy's Laboratories have entered a strategic development and commercialization partnership on NeuVax(NYSE:TM) (nelipepimut-S) in India.

    Dr. Reddy's is an integrated pharmaceutical company focused on providing affordable and innovative medicines for healthier lives. By partnering with this global pharmaceutical company, Gelena has expanded the depth of its pipeline by increasing the clinical utility of NeuVax in another unmet medical need.

    "This partnership with Dr. Reddy's is consistent with our strategy to expand the clinical utility of NeuVax in unmet medical needs while simultaneously increasing the commercial footprint of this innovative cancer immunotherapy," said Mark J. Ahn, Ph.D., President and CEO of Galena Biopharma. "Dr. Reddy's is a leading pharmaceutical company in India with significant commercialization and development expertise. The gastric cancer trial will add a significant indication to our pipeline for NeuVax, while doubling our potential patient population if approved."

    G V Prasad, Chairman and CEO, Dr. Reddy's commented, "The partnership accelerates our strong commitment to innovation and efforts to bring newer options for cancer patients. We are delighted with our partnership with Galena Biopharma and we believe NeuVax can be a good potential treatment option to prevent the recurrence of breast and gastric cancer."

    For more information, visit or

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit

    Stocks: GALE
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.